anmelden
AstraZeneca Aktie
153,40
EUR
+2,45
EUR
+1,62
%
153,40
EUR
+1,20
EUR
+0,79
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 22.11.19 | AstraZeneca overweight | Barclays Capital | |
| 12.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.10.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 29.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 25.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca overweight | Barclays Capital | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | Barclays Capital | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca overweight | Barclays Capital | |
| 26.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 08.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 27.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.05.19 | AstraZeneca overweight | Barclays Capital | |
| 13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
Werbung
Werbung